Impairment of lymphocyte function following yttrium-90 DOTATOC therapy

In conclusion, DOTATOC therapy caused a decrease in in vitro immune responses against microorganisms. The clinical impact needs to be evaluated in further studies.

Source: Cancer Immunology, Immunotherapy - March 30, 2015 Category: Cancer & Oncology Source Type: research